secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sana Biotechnology, Inc. (SANA)
CIK:        0001770121
Form:       8-K
Filed at:   2025-08-29T23:59:59+00:00
Accession:  0001193125-25-192766
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sana Biotechnology director Mary Agnes Wilderotter resigns effective Aug 29
---------------------------------------------------------------------------

- Mary Agnes Wilderotter resigned as director and chair of Nominating and Corporate Governance Committee, effective Aug 29, 2025.
- She also resigned from the Audit Committee. Resignation not due to any disagreement with Sana's operations, policies, or practices.
- No replacement or further board changes announced in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770121/000119312525192766/0001193125-25-192766-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770121/000119312525192766/sana-20250828.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-192766

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer